Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Patterns of use, dosing, and economic impact of biologic agent use in patients with rheumatoid arthritis: a retrospective cohort study.
Gilbert TD Jr, Smith D, Ollendorf DA. Gilbert TD Jr, et al. Among authors: ollendorf da. BMC Musculoskelet Disord. 2004 Oct 14;5(1):36. doi: 10.1186/1471-2474-5-36. BMC Musculoskelet Disord. 2004. PMID: 15485582 Free PMC article.
Impact of atypical antipsychotics on outcomes of care in schizophrenia.
Joyce AT, Harrison DJ, Loebel AD, Ollendorf DA. Joyce AT, et al. Among authors: ollendorf da. Am J Manag Care. 2005 Sep;11(8 Suppl):S254-61. Am J Manag Care. 2005. PMID: 16180964
Frequency, predictors, and economic impact of upward dose adjustment of infliximab in managed care patients with rheumatoid arthritis.
Ollendorf DA, Massarotti E, Birbara C, Burgess SM. Ollendorf DA, et al. J Manag Care Pharm. 2005 Jun;11(5):383-93. doi: 10.18553/jmcp.2005.11.5.383. J Manag Care Pharm. 2005. PMID: 15934797
Infliximab drug and infusion costs among patients with Crohn's disease in a commercially-insured setting.
Ollendorf DA, Lidsky L. Ollendorf DA, et al. Am J Ther. 2006 Nov-Dec;13(6):502-6. doi: 10.1097/01.mjt.0000245223.43783.45. Am J Ther. 2006. PMID: 17122530
An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.
Black L, Naslund MJ, Gilbert TD Jr, Davis EA, Ollendorf DA. Black L, et al. Among authors: ollendorf da. Am J Manag Care. 2006 Mar;12(4 Suppl):S99-S110. Am J Manag Care. 2006. PMID: 16551208
Impact of leflunomide versus biologic agents on the costs of care for rheumatoid arthritis in a managed care population.
Ollendorf DA, Peterson AN, Doyle J, Huse DM. Ollendorf DA, et al. Am J Manag Care. 2002 May;8(7 Suppl):S203-13. Am J Manag Care. 2002. PMID: 12022236
Differences in annual medication costs and rates of dosage increase between tumor necrosis factor-antagonist therapies for rheumatoid arthritis in a managed care population.
Ollendorf DA, Klingman D, Hazard E, Ray S. Ollendorf DA, et al. Clin Ther. 2009 Apr;31(4):825-35. doi: 10.1016/j.clinthera.2009.04.002. Clin Ther. 2009. PMID: 19446156
End-stage renal disease-associated managed care costs among patients with and without diabetes.
Joyce AT, Iacoviello JM, Nag S, Sajjan S, Jilinskaia E, Throop D, Pedan A, Ollendorf DA, Alexander CM. Joyce AT, et al. Among authors: ollendorf da. Diabetes Care. 2004 Dec;27(12):2829-35. doi: 10.2337/diacare.27.12.2829. Diabetes Care. 2004. PMID: 15562193
Effect of initial ziprasidone dose on length of therapy in schizophrenia.
Joyce AT, Harrison DJ, Loebel AD, Carter CT, Ollendorf DA. Joyce AT, et al. Among authors: ollendorf da. Schizophr Res. 2006 Apr;83(2-3):285-92. doi: 10.1016/j.schres.2006.01.009. Epub 2006 Mar 20. Schizophr Res. 2006. PMID: 16545543 Clinical Trial.
Economic consequences of venous thromboembolism following major orthopedic surgery.
Oster G, Ollendorf DA, Vera-Llonch M, Hagiwara M, Berger A, Edelsberg J. Oster G, et al. Among authors: ollendorf da. Ann Pharmacother. 2004 Mar;38(3):377-82. doi: 10.1345/aph.1C518. Epub 2004 Jan 12. Ann Pharmacother. 2004. PMID: 14742829
80 results
Jump to page
Feedback